BH Global Corporation Limited (SGX:BQN)

Ligand Pharmaceuticals Balance Sheet

Financials in millions SGD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3.1	5.3	5.31	5.74	9.6	12.07
Cash & Short-Term Investments	3.1	5.3	5.31	5.74	9.6	12.07
Cash Growth	5.27%	-0.07%	-7.53%	-40.25%	-20.46%	93.90%
Accounts Receivable	12.74	14.57	17.56	16.29	11.39	9.25
Other Receivables	4.99	3.9	2.84	1.9	1.65	1.52
Receivables	17.73	18.46	20.39	18.18	13.04	10.77
Inventory	34.42	33.26	30.74	33	31.02	33.04
Prepaid Expenses	-	0.45	0.49	0.34	0.3	0.31
Other Current Assets	-	0.62	1.27	2.42	1.95	1.52
Total Current Assets	55.25	58.1	58.2	59.68	55.9	57.7
Property, Plant & Equipment	16.79	16.98	17.48	17.61	18.33	18.81
Long-Term Investments	3.43	3.42	2.89	2.73	2.4	2.83
Goodwill	-	0.29	0.29	0.29	0.29	0.19
Other Intangible Assets	5.69	-	-	-	-	-
Long-Term Deferred Tax Assets	1.27	1.48	1.36	1.06	0.48	0.01
Long-Term Deferred Charges	-	5.38	4.64	3.23	3.24	3.05
Total Assets	85.24	88.84	88.36	88.12	84.63	86.59
Accounts Payable	6.97	5.52	5.52	7.18	5.79	3.03
Accrued Expenses	-	2.82	3.24	4.17	2.72	4.58
Short-Term Debt	-	10.82	5.27	3.8	1.33	8.71
Current Portion of Long-Term Debt	12.36	1.05	1.38	1.88	1.86	1.04
Current Portion of Leases	0.36	0.36	0.37	0.33	0.47	0.52
Current Income Taxes Payable	1.49	1.86	2.85	2	1.35	1.34
Current Unearned Revenue	1.78	1.89	4.01	3.05	3.36	3.34
Other Current Liabilities	2.35	0.49	0.78	0.61	1.05	1.34
Total Current Liabilities	25.31	24.81	23.41	23.02	17.93	23.89
Long-Term Debt	0.16	0.47	1.58	2.91	4.79	3.79
Long-Term Leases	7.89	7.73	7.66	7.89	8.18	8.37
Long-Term Deferred Tax Liabilities	0.31	0.31	0.31	0.27	0.25	0.26
Total Liabilities	33.67	33.32	32.96	34.08	31.14	36.31
Common Stock	58.54	58.54	58.54	58.54	58.54	58.54
Retained Earnings	-2.5	0.38	-0.31	-1.97	-2.98	-6.52
Comprehensive Income & Other	-4.28	-1.8	-1.93	-2.43	-2.39	-2.55
Total Common Equity	51.75	57.12	56.3	54.14	53.17	49.47
Minority Interest	-0.18	-1.6	-0.89	-0.11	0.32	0.82
Shareholders' Equity	51.57	55.52	55.41	54.03	53.49	50.29
Total Liabilities & Equity	85.24	88.84	88.36	88.12	84.63	86.59
Total Debt	20.77	20.44	16.26	16.8	16.62	22.42
Net Cash (Debt)	-17.67	-15.14	-10.95	-11.06	-7.02	-10.35
Net Cash Per Share	-	-0.05	-0.04	-0.04	-0.02	-0.03
Filing Date Shares Outstanding	-	300	300	300	300	300
Total Common Shares Outstanding	-	300	300	300	300	300
Working Capital	29.94	33.29	34.79	36.66	37.98	33.81
Book Value Per Share	-	0.19	0.19	0.18	0.18	0.16
Tangible Book Value	46.06	56.83	56.02	53.85	52.88	49.29
Tangible Book Value Per Share	-	0.19	0.19	0.18	0.18	0.16
Machinery	-	8.65	8.27	7.78	7.97	7.39

Updated Aug 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.